Medical stocks continue to show healthy action, both in the U.S. and abroad. But those based outside the states might have the upper hand. Six of the top 10 companies by Composite Rating in the ethical drugmakers group are headquartered outside the United States. The group is ranked No. 6 among IBD’s 197 industry groups, up from No. 11 six weeks ago.